Subjects: CARCINOMA, CICLINAS, PROTEÍNAS PROTO-ONCOGÊNICAS, NEOPLASIAS OVARIANAS, RNA MENSAGEIRO
ABNT
KANG, Eun-Young et al. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: an ovarian tumor tissue analysis consortium study. Cancer, v. 129, n. 5, p. 697-713, 2023Tradução . . Disponível em: https://doi.org/10.1002/cncr.34582. Acesso em: 03 jan. 2026.APA
Kang, E. -Y., Weir, A., Meagher, N. S., Farrington, K., Nelson, G. S., Ghatage, P., et al. (2023). CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: an ovarian tumor tissue analysis consortium study. Cancer, 129( 5), 697-713. doi:10.1002/cncr.34582NLM
Kang E-Y, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Bolithon A, Reis FJC dos, Köbel M. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: an ovarian tumor tissue analysis consortium study [Internet]. Cancer. 2023 ; 129( 5): 697-713.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1002/cncr.34582Vancouver
Kang E-Y, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Bolithon A, Reis FJC dos, Köbel M. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: an ovarian tumor tissue analysis consortium study [Internet]. Cancer. 2023 ; 129( 5): 697-713.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1002/cncr.34582
